Ying-Qing Li
Overview
Explore the profile of Ying-Qing Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
267
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liang Y, Liu X, Shen L, Hu G, Zou G, Zhang N, et al.
JAMA
. 2025 Mar;
PMID: 40079940
Importance: Approximately 20% to 30% of patients with locoregionally advanced nasopharyngeal carcinoma (NPC) experience disease relapse despite definitive chemoradiotherapy. The programmed cell death 1 (PD-1) blockade camrelizumab has demonstrated considerable...
2.
Zeng L, Li Y, He S, Xu H, Zhang R, Chen K, et al.
Neuro Oncol
. 2024 Aug;
27(2):492-507.
PMID: 39215663
Background: Dysregulated deubiquitinating enzymes (DUBs) execute as intrinsic oncogenes or tumor suppressors and are involved in chemoresistance in cancers. However, the functions and exact molecular mechanisms remain largely unclear in...
3.
Gong S, Qiao H, Wang J, Huang S, He S, Zhao Y, et al.
Oncogene
. 2024 Aug;
43(38):2868-2884.
PMID: 39154122
The dysregulation of long non-coding RNAs (lncRNAs) are involved in regulating tumor progression in multiple manner. However, little is known about whether lncRNA is involved in the translation regulation of...
4.
Huang S, Gong S, Zhao Y, Ye M, Li J, He Q, et al.
Nat Commun
. 2024 Jun;
15(1):5300.
PMID: 38906860
Chemoresistance is a main reason for treatment failure in patients with nasopharyngeal carcinoma, but the exact regulatory mechanism underlying chemoresistance in nasopharyngeal carcinoma remains to be elucidated. Here, we identify...
5.
Liu X, Zhang Y, Yang K, Zhang N, Jin F, Zou G, et al.
Lancet
. 2024 Jun;
403(10445):2720-2731.
PMID: 38824941
Background: Anti-PD-1 therapy and chemotherapy is a recommended first-line treatment for recurrent or metastatic nasopharyngeal carcinoma, but the role of PD-1 blockade remains unknown in patients with locoregionally advanced nasopharyngeal...
6.
Zhou S, Feng P, Ye M, Huang S, He S, Zhu X, et al.
J Exp Clin Cancer Res
. 2024 Jan;
43(1):14.
PMID: 38191501
Background: Metastasis has emerged as the major reason of treatment failure and mortality in patients with nasopharyngeal carcinoma (NPC). Growing evidence links abnormal DNA methylation to the initiation and progression...
7.
Zhang Q, Feng P, Zhu X, Zhou S, Ye M, Yang X, et al.
Cell Death Dis
. 2023 Oct;
14(10):697.
PMID: 37875476
Emerging evidence indicates that DNA methylation plays an important role in the initiation and progression of nasopharyngeal carcinoma (NPC). DNAJA4 is hypermethylated in NPC, while its role in regulating NPC...
8.
Wang J, Cheng X, Li Z, Mao Y, Wang X, Zhang K, et al.
Arch Gynecol Obstet
. 2023 Sep;
310(2):833-842.
PMID: 37773466
Background: It has been suggested that gestational diabetes mellitus (GDM) alters the growth trajectory of a fetus and increases the risk of abnormal birth weight. In spite of this, there...
9.
Huang K, Feng L, Liu Z, Li Z, Mao Y, Wang X, et al.
Environ Geochem Health
. 2023 Aug;
45(11):8187-8202.
PMID: 37552412
We aimed to characterize the association between air pollutants exposure and periodontal diseases outpatient visits and to explore the interactions between ambient air pollutants and meteorological factors. The outpatient visits...
10.
Huang S, Wu L, Qiu Y, Xie Y, Wu H, Li Y, et al.
J Cancer Res Clin Oncol
. 2023 Jul;
149(14):13107-13122.
PMID: 37474680
Background: Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer that exhibits elevated glycolytic capacity. Lactate, as a byproduct of glycolysis, is considered a major oncometabolite that...